CYTEK BIOSCIENCES, INC. Business Combination, Acquisition Related Costs
CYTEK BIOSCIENCES, INC. (CTKB) reported Business Combination, Acquisition Related Costs of $1.50 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2024-03-13
- CYTEK BIOSCIENCES, INC. business combination, acquisition related costs for the quarter ending 2023-12-31 was $0.00.
- CYTEK BIOSCIENCES, INC. business combination, acquisition related costs for the quarter ending 2023-09-30 was $0.00.
- CYTEK BIOSCIENCES, INC. business combination, acquisition related costs for the quarter ending 2023-06-30 was $0.00.
- CYTEK BIOSCIENCES, INC. business combination, acquisition related costs for the quarter ending 2023-03-31 was $1.50M.
- CYTEK BIOSCIENCES, INC. business combination, acquisition related costs for fiscal 2023 was $1.50M.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $0.00 derived: sum of 2 quarters · filed 2024-03-13 | $0.00 derived: sum of 3 quarters · filed 2024-03-13 | $1.50M 10-K · filed 2024-03-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $1.50M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | $1.50M 10-Q · filed 2023-08-08 | ||
| 2023-03-31 | $1.50M derived: 10-K 12 month − 3 quarters · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |